PhRMA launches first ever industry-wide principles on clinical trial diversity
In November 2020, PhRMA member companies launched the first ever industry-wide principles on clinical trial diversity. These principles build on our commitment to earn trust and address the systemic issues that deter Black and Brown communities from participating in clinical trials, so that people who want to participate, can.
Diversity is critical to the work we do.
Diversity is essential to a robust innovation ecosystem that can create new medicines for those who need them. America’s biopharmaceutical companies are pushing for necessary, positive and long-term change to better meet the needs of Black and Brown America.
PhRMA statement on presidential executive order restricting diversity training
Our companies have committed to pushing for necessary, positive, long-term change to better address the needs of diverse communities. It is why we spoke out against an executive order restricting workplace diversity training programs.